Document is current

Any future updates will be listed below

First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2021.07.003

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

About CrossMark